Biomarker Testing
Our biomarker testing services help you identify, validate, and quantify biomarkers that can be used to assess the effectiveness and safety of your product candidates throughout the development process.
Exclusive Biomarkers
Our proprietary collagen biomarkers COLL2-1 and COLL2-1NO2 are qualified as biomarkers of osteoarthritis according to BIPED classification. They have been cited in over 37 peer-reviewed publications and used as endpoints for several clinical trials.
Portfolio
We have a biomarker portfolio of more than 40 biomarkers, validated for use in human, rat, mouse, dog, sheep, and guinea pig samples.
Biomarker measurements
Biomarkers are being assessed following GCLP.
Biomarkers can be measured in different matrices, including serum, plasma, urine, or synovial fluid.
In addition to human samples, we offer biomarker measurements in in vitro or in vivo animal models, such as cell culture systems, as well as a variety of different species.
We propose colorimetric immunoassays (ELISA) and multiplex measurements using MSD or Luminex technology.
Commercial biomarkers
We propose a large panel of validated commercially available ELISA or multiplex kits. Validation of any commercially available ELISA or multiplex kits by assessing dilution linearity, intra-assay variability, inter-assay variability is possible. Please contact us if you don’t find your biomarker of interest in our portfolio, we can validate any commercially available kit!
Learn about the latest trends
Receive the latest on industry insights & Artialis news.
Learn about the latest trends
Receive the latest on industry insights & Artialis news.